Skip to main content
BLINKLAB LIMITED logo

BLINKLAB LIMITED — Investor Relations & Filings

Ticker · BB1 ISIN · AU0000322851 LEI · 529900BTGD6TA3TPLS56 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 164 across all filing types
Latest filing 2026-05-21 Proxy Solicitation & In…
Country AU Australia
Listing ASX BB1

About BLINKLAB LIMITED

https://www.blinklab.org

BlinkLab Limited is a digital health technology company specializing in the development of smartphone-based diagnostic platforms for neurodevelopmental and neurodegenerative disorders. The company utilizes advanced computer vision and machine learning algorithms to transform standard smartphones into clinical-grade tools for neurological assessment. Its core technology focuses on the eyeblink conditioning paradigm, a well-established biomarker for brain function, to screen for conditions such as Autism Spectrum Disorder (ASD), ADHD, and schizophrenia. By enabling remote, objective, and scalable testing, BlinkLab aims to facilitate early intervention and continuous monitoring outside of traditional clinical settings. The platform is designed to provide healthcare professionals with data-driven insights to improve diagnostic accuracy and patient outcomes in the field of behavioral health and neurology.

Recent filings

Filing Released Lang Actions
Notice of General Meeting & Proxy Form 38 pages 690.8KB
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a Notice of General Meeting and Explanatory Memorandum sent to shareholders outlining resolutions to be voted on, voting exclusions, meeting details, and an explanatory statement. It is pre-meeting solicitation material designed to inform and request votes, matching the Proxy Solicitation & Information Statement definition.
2026-05-21 English
Letter to Shareholders & Proxy Form 3 pages 301.4KB
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a Notice of General Meeting and accompanying proxy voting form sent to shareholders to provide information on resolutions and solicit votes. It is not the actual AGM materials/presentation, nor the results of any vote, nor a financial report, but rather the proxy solicitation and information statement for an upcoming meeting. Therefore, it matches the Proxy Solicitation & Information Statement category (PSI).
2026-05-21 English
Therapy Evaluation for Neurodevelopmental Conditions 3 pages 241.0KB
Regulatory Filings Classification · 85% confidence The document is an ASX corporate announcement describing a research partnership and strategic expansion of BlinkLab’s platform. It does not contain financial results, management changes, dividend notices, regulatory report attachments, or detailed financial statements. It is a general regulatory announcement to the ASX and does not fit any of the more specific categories, so it is classified as a Regulatory Filing (RNS).
2026-05-18 English
BB1 to present at Stocks in the Vines Investor Access Day 2 pages 277.5KB
Regulatory Filings Classification · 85% confidence The document is a short ASX announcement (press release) notifying the market that the company’s Chairman will present at an investor event (“Stocks in the Vines Investor Access Day”). It does not contain substantive financial statements or slides, nor is it a full report publication. It is simply a general regulatory/market announcement, fitting the fallback category Regulatory Filings (RNS).
2026-05-13 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 559.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report For The Period Ended 31 March 2026' and includes detailed operational highlights, clinical study progress, scientific leadership updates, and a financial summary including cash flow data for the quarter. It also contains an Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules. The content is comprehensive and includes substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). It is not merely an announcement of a report or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2026
2026-04-29 English
Application for quotation of securities - BB1 6 pages 18.5KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 2A “Application for quotation of securities” detailing the quotation of newly issued ordinary shares under an earlier Appendix 3B placement. It announces the issue and quotation of 26,964,674 new fully paid shares, the issue price, and the post-issue capital structure. This is a direct announcement of a new share issue/capital change. Hence it is classified as a Share Issue/Capital Change (SHA).
2026-04-22 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.